Hyposalivation, xerostomia and oral health status of HIV-infected subjects in Thailand before HAART era

Journal of Oral Pathology and Medicine

Volumn 39, Issue 1, 2010, Pages 28-34

  Nittayananta, Wipawee ^a   Chanowanna, Nilnara ^a   Jealae, Sureerath ^a   Nauntofte, Birgitte ^b   Stoltze, Kaj ^b  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

HIV; Hyposalivation; Oral health; Risk factor; Salivary flow rate; Xerostomia

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; PSYCHOTROPIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANDIDA; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DENTAL CARIES; DISEASE ASSOCIATION; FEMALE; FLOW RATE; HEALTH STATUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOSALIVATION; MALE; PRIORITY JOURNAL; RISK FACTOR; SALIVATION; THAILAND; THRUSH; XEROSTOMIA;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANALGESICS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CANDIDIASIS, ORAL; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HISTAMINE ANTAGONISTS; HIV INFECTIONS; HIV SERONEGATIVITY; HUMANS; LYMPHOCYTE COUNT; MALE; ORAL HEALTH; PSYCHOTROPIC DRUGS; RISK FACTORS; ROOT CARIES; SALIVA; SECRETORY RATE; THAILAND; TOOTH LOSS; XEROSTOMIA; YOUNG ADULT;

EID: 76249098259     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00826.x     Document Type: Article

References (52)

1. Fox PC. Salivary gland involvement in HIV-1 infection. Oral Surg Oral Med Oral Pathol 1992 73 : 168 170.
2. Schiødt M, Dodd CL, Greenspan D, et al. Natural history of HIV-associated salivary gland disease. Oral Surg Oral Med Oral Pathol 1992 74 : 326 331.
3. Silvermann Sjr, Migliorati CA, Lozada-Nur F, Greenspan D, Conant MA. Oral findings in people with or at a high risk for AIDS; a study of 375 homosexual males. J Am Dent Assoc 1986 112 : 187 192.
4. Ramirez V, Gonzalez A, de la Rosa E, et al. Oral lesions in Mexican HIV-infected patients. J Oral Pathol Med 1990 19 : 482 485.
5. Laskaris G, Hadjivassiliou M, Stratigos J. Oral signs and symptoms in 160 Greek HIV-infected patients. J Oral Pathol Med 1992 21 : 120 123.
6. Glick M, Muzyka BC, Lurie D, et al. Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol 1994 77 : 344 349.
7. Nittayananta W, Chungpanich S. Oral lesions in a group of Thai people with AIDS. Oral Dis 1997 3 (Suppl. 1 1 5.
8. Navazesh M. Dry mouth: aging and oral health. Compend Contin Educ Dent 2002 23 (Suppl. 41 8.
9. Mandel ID, Barr CE, Turgeon L. Longitudinal study of parotid saliva in HIV-1 infection. J Oral Pathol Med 1992 21 : 209 213.
10. Sweet SP, Rahman D, Challacombe SJ. IgA subclasses in HIV-disease: dichotomy between raised levels in serum and decreased secretion rates in saliva. Immunology 1995 86 : 556 559.
11. Atkinson JC, Schiødt M, Robataille S, Greenspan D, Greenspan JS, Fox PC. Salivary autoantibodies in HIV-associated salivary gland disease. J Oral Pathol Med 1993 22 : 203 206.
12. Dodd CL, Greenspan D, Westenhause JL, Katz MH. Xerostomia associated with didanosine. Lancet 1992 340 : 790.
13. Patton LL, McKaig R, Strauss R, Rogers D, Eron JJ Jr. Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000 89 : 299 304.
14. Dios PD, Scully C. Adverse effects of antiretroviral therapy: focus on orofacial effects. Exp Opin Drug Safety 2002 1 : 307 317.
15. World Health Organization acquired immunodeficiency syndrome (AIDS): Interim proposal for a WHO staging system for HIV infection and disease. Wkly Epidem Rec 1990 65 : 221 228.
16. Sreebny LM, Schwartz SS. A reference guide to drugs and dry mouth. Gerontology 1986 5 : 75 99.
17. Navazesh M, Christensen CM. A comparison of whole mouth resting and stimulated salivary measurement procedures. J Dent Res 1982 61 : 1158 1162.
18. EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus. Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med 1993 22 : 289 291.
19. Samaranayake LP, McFarlane TW, Lamey PJ, Ferguson MM. A comparison of oral rinse culture and imprint culture technique for the detection of oral yeast carriage. J Oral Pathol 1986 15 : 251 254.
20. Samaranayake LP, Holmstrup P. Oral candidiasis and human immunodeficiency virus infection. J Oral Pathol Med 1989 18 : 554 564.
21. Navazesh M, Christensen C, Brightman V. Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res 1992 71 : 1363 1369.
22. Sreebny LM, Valdini A, Brook S. Xerostomia. Part I: Relationship to other oral symptoms and salivary gland hypofunction. Oral Surg Oral Med Oral Pathol 1988 66 : 451 458.
23. Fox PC, van der Ven PF, Sonies BC, Weiffenbach JM, Baum BJ. Xerostomia: evaluation of a symptom with increasing significance. J Am Dent Assoc 1985 110 : 519 525.
24. Mandel ID. The role of saliva in maintaining oral homeostasis. J Am Dent Assoc 1989 119 : 298 303.
25. Navazesh M. Salivary gland hypofunction in elderly patients. J Calif Dent Assoc 1994 22 : 62 8.
26. Atkinson JC, Wu AJ. Salivary gland dysfunction: causes, symptoms, treatment. J Am Dent Assoc 1994 125 : 409 416.
27. Navazesh M, Brightman VJ, Pogoda JM. Relationship of medical status, medications, and salivary flow rates in adults of different ages. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996 81 : 172 176.
28. Persson RE, Izutsu KT, Truelove EL, Persson R. Differences in salivary flow rates in elderly subjects using xerostomic medications. Oral Surg Oral Med Oral Pathol 1991 72 : 42 6.
29. Naerhi TO, Meurman JH, Ainamo A, et al. Association between salivary flow rate and the use of systemic medication among 76-, 81-, and 86-year-old inhabitants in Helsinki, Finland. J Dent Res 1992 71 : 1875 1880.
30. Wu AJ, Ship JA, Arbor A. A characterization of major salivary gland flow rates in the presence of medications and systemic diseases. Oral Surg Oral Med Oral Pathol 1993 76 : 301 306.
31. Oesterberg T, Landahl S, Hedegard B. Saliva flow, saliva pH, and buffering capacity in 70-year-old men and women: correlation to dental health, dryness in the mouth disease, and drug treatment. J Oral Rehabil 1984 11 : 157 170.
32. Handelman SL, Baric JM, Saunders RH, Espeland MA. Hyposalivatory drug use, whole unstimulated salivary flow, and mouth dryness in older, long-term residents. Spec Care Dent 1989 9 : 12 8.
33. Thomson WM, Brown RH, Williams SM. Medication and perception of dry mouth in a population of institutionalized elderly people. N Z Med J 1993 106 : 219 221.
34. Marder MZ, Barr CE, Mandel ID. Cytomegalovirus presence and salivary composition in acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol 1985 60 : 372 376.
35. Müller F, Holberg-Petersen M, Rollag H, Degré M, Brandtzaeg P, Frøland SS. Nonspecific oral immunity in individuals with HIV infection. J Acquir Immune Defic Syndr 1992 5 : 46 51.
36. Atkinson JC, Travis WD, Pillemer SR, Bermudez D, Wolff A, Fox PC. Major salivary gland function in primary Sjogren's syndrome and its relationship to clinical features. J Rheumatol 1990 17 : 318 322.
37. Tsang C, Samaranayake L. Salivary lysozyme and related parameters of a predominantly Chinese, HIV-infected cohort in Hong Kong. Oral Dis 1999 5 : 241 246.
38. Fox PC. Saliva and salivary gland alterations in HIV infection. J Am Dent Assoc 1991 122 : 46 8.
39. Parvinen T, Larmas M. Age dependency of stimulated salivary flow rate, pH, and lactobacillus and yeast concentrations. J Dent Res 1982 61 : 1052 1055.
40. Holmes JH. Changes in salivary flow produced by changes in fluid and electrolyte balance. In : Sreebny LM, Meyer J, eds. Salivary glands and their secretions. New York : MacMillian, 1964 177 195.
41. Dawes C, Cross HG, Baker CG, Chebib FS. The influence of gland size on the flow rate and composition of human parotid saliva. J Can Dent Assoc 1978 44 : 21 5.
42. Baum BJ. Evaluation of stimulated parotid saliva flow rate in different age groups. J Dent Res 1981 60 : 1292 1296.
43. Heft MW, Baum BJ. Unstimulated and stimulated parotid salivary flow rate in individuals of different ages. J Dent Res 1984 63 : 1182 1185.
44. Tylenda CA, Ship JA, Fox PC, Baum BJ. Evaluation of submandibular salivary flow rate in different age groups. J Dent Res 1988 67 : 1225 1228.
45. Schiødt M, Pindborg JJ. AIDS and the oral cavity. Epidemiology and clinical oral manifestations of human immune deficiency virus infection: a review. Int J Oral Maxillofac Surg 1987 16 : 1 14.
46. Bardow A, Nyvad B, Nauntofte B. Relationships between medication intake, complaints of dry mouth, salivary flow rate and composition, and the rate of tooth demineralization in situ. Arch Oral Biol 2001 46 : 413 423.
47. Flink H, Bergdahl M, Tegelberg A, Rosenblad A, Lagerlöf F. Prevalence of hyposalivation in relation to general health, body mass index and remaining teeth in different age groups of adults. Community Dent Oral Epidemiol 2008 36 : 523 531.
48. Pollock JJ, Santarpia RP 3rd., Heller HM, et al. Determination of salivary anticandidal activities in healthy adults and patients with AIDS: a pilot study. J Acquir Immune Defic Syndr 1992 5 : 610 618.
49. McCarthy GM, Mackie ID, Koval J, Sandhu HS, Daley TD. Factors associated with increased frequency of HIV-related oral candidiasis. J Oral Pathol Med 1991 20 : 332 336.
50. Edgar WM, O'Mullane DM. Saliva and dental health. Clinical implications of saliva and salivary stimulation for better dental health in the 1990s. Report of a Consensus Workshop held at Ashford Castle, July 2-5, 1989, Ireland : Co Mayo, 1989.
51. Kitamura M, Kiyak HA, Mulligan K. Predictors of root caries in the elderly. Community Dent Oral Epidemiol 1986 14 : 34 8.
52. Patel M, Shackleton JA, Coogan MM, Galpin J. Antifungal effect of mouth rinses on oral Candida counts and salivary flow in treatment-naïve HIV-infected patients. AIDS Patient Care STDS 2008 22 : 613 618.